NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DA-20-093 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-20-060 from the NIH Guide for Grants and Contracts. This initiative will support the use of longitudinal cohorts to develop greater understanding of important elements of influenza immunity that impact vaccine response and vaccine effectiveness in older adults (those 65 and older). In addition, this work will increase our understanding of how these elements relate to severe outcomes from influenza virus infection in older adults (i.e., hospitalization and death).
Notice NOT-NS-21-004 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-179 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-110 from the NIH Guide for Grants and Contracts
Notice NOT-OH-20-014 from the NIH Guide for Grants and Contracts
Notice NOT-HD-20-031 from the NIH Guide for Grants and Contracts
Notice NOT-HG-21-010 from the NIH Guide for Grants and Contracts
Notice NOT-MD-21-001 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-044 from the NIH Guide for Grants and Contracts. The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, and serum) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study. Information about the PATH Study and this resource may be found on the PATH Study series page at the University of Michigans National Addiction and HIV Data Archive Program (NAHDAP) website, part of the Inter-University Consortium for Political and Social Researchs (ICPSR) website.
Funding Opportunity RFA-AI-20-057 from the NIH Guide for Grants and Contracts. To support research to better define the role of the granuloma, the hallmark structure of pulmonary tuberculosis (TB), in TB disease and disease outcomes. Improved understanding of the granuloma will provide a much-needed knowledge base for the development of improved therapeutic approaches.
Notice NOT-PM-20-002 from the NIH Guide for Grants and Contracts
Notice NOT-OH-20-015 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-050 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-305 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are derived from the same organ system, such as gastrointestinal, neuroendocrine, head and neck, and other cancers. Other programmatically appropriate groups of cancers may include those centered around a common biological mechanism critical for promoting tumorigenesis and/or cancer progression in organ sites that belong to different organ systems. For example, a SPORE may focus on cancers caused by the same infectious agent or cancers promoted and sustained by dysregulation of a common signaling pathway. In addition, a SPORE may focus on cross-cutting themes such as pediatric cancers or cancer health disparities. The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant.
Notice NOT-MD-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-GM-20-055 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-001 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-176 from the NIH Guide for Grants and Contracts